Product Information
METHYLPHENIDATE 20 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.2014 per EA under NDC 43547048810. Its NADAC has been published 276 times since Jun 23, 2021.
FDA first approved this application on Jul 23, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547048810
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212697FDA Approved
7/23/2020
TE Code
AB
On Market Since
7/1/2020
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE 20 MG TABLET has been published 276 times since Jun 23, 2021, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2014 per EA |
|---|---|
| All-time high | $0.2532 (Oct 16, 2024) |
| All-time low | $0.1079 (Apr 17, 2024) |
| 52-week high | $0.2332 |
| 52-week low | $0.1962 |
| Median price | $0.2024 |
| Average price | $0.1999 |
| Largest weekly change | +108.2% (Aug 21, 2024) |
| Weeks tracked | 276 |
| Tracking since | Jun 23, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Methylphenidate hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Solco Healthcare US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Methylphenidate hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE 20 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.2014 per EA (NDC 43547048810), effective Sep 30, 2026.
How has the price of METHYLPHENIDATE 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE 20 MG TABLET has held within roughly two percent of its current level. It has been tracked across 276 weekly CMS publications since Jun 23, 2021.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE 20 MG TABLET?
Since Jun 23, 2021, the NADAC for METHYLPHENIDATE 20 MG TABLET has ranged from a low of $0.1079 (Apr 17, 2024) to a high of $0.2532 (Oct 16, 2024), with a median of $0.2024 per EA.
Are there cheaper alternatives to METHYLPHENIDATE 20 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of METHYLPHENIDATE 20 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures METHYLPHENIDATE 20 MG TABLET?
METHYLPHENIDATE 20 MG TABLET (NDC 43547048810) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.